Caring Brands, Inc. filings document the company's securities registration, capital structure, governance changes, and material events as a Nasdaq-listed wellness consumer products issuer. Its S-1 registration materials describe common stock offerings, business disclosures, risk factors, financial statements, and the company's OTC and cosmetic product focus.
Recent 8-K filings cover Nasdaq continued-listing compliance, amendments to shareholder-meeting quorum requirements, executive finance-function changes, and financing transactions involving Series A Convertible Preferred Stock, common warrants, and insider share redemptions. Other event disclosures record patent-related updates for the Hair Enzyme Booster product and related intellectual property matters.
Caring Brands, Inc. (CABR) registered for resale by selling stockholders up to 24,513,943 shares of common stock: 10,214,143 shares underlying Series B Preferred Stock and 7,149,900 shares under each of the Series A and Series B Warrants. The original conversion price was $0.70 per share; original exercise prices were $0.825 and $0.95 per share, respectively, and are subject to adjustment. The company receives no proceeds from resales or preferred-stock conversions; it may receive cash from cash warrant exercises, while cashless exercises yield no proceeds.
The Series B financing raised gross proceeds of $7,149,900. Common shares outstanding were 10,468,226 as of October 22, 2026.
Caring Brands reported no revenue and a net loss of $2,647,202 for the six months ended June 30, 2026, and a net loss of $6,278,191 for 2025. It says its working-capital deficiency and limited operations raise substantial doubt about its ability to continue as a going concern. Nasdaq issued a delisting determination on July 15, 2026, which the company appealed. The company submitted preliminary, unaudited pro forma equity of $8,220,419 as of August 31, 2026, subject to final accounting and review; Nasdaq had not formally confirmed compliance.
Caring Brands, Inc. (CABR) amended its Series A and Series B preferred-stock terms and its PIPE warrants to establish minimum conversion or exercise prices. The Series A conversion floor is $0.16 per share and became effective September 22, 2026; the Series B conversion floor and PIPE warrant exercise-price floor are $0.266 per share and became effective September 30, 2026.
The floors override specified adjustments and calculations that would otherwise produce lower prices. The stated initial exercise prices of Warrant A, $0.825 per share, and Warrant B, $0.95 per share, were not reset. The warrant amendment may reduce shares issuable compared with the unamended terms, and excess shares calculated using a price below the floor are not due. The amendments do not assure any particular accounting classification or Nasdaq determination.
Caring Brands, Inc. (CABR) reported that Chief Executive Officer Glynn Wilson received a direct grant of options covering 75,000 common shares on October 6, 2026, under the company’s equity incentive plan, following board approval on the Compensation Committee’s recommendation. The options vested immediately, have a $1.13 exercise price and expire October 6, 2031. Wilson’s reported beneficial ownership after the transaction was 747,592 shares, including 126,720 and 45,872 unvested restricted stock units and 500,000 common shares.
Caring Brands, Inc. director Hector W. Alila received a grant of 50,000 stock options on September 28, 2026, under the company's equity incentive plan. The options vested immediately, have an exercise price of $1.24 per share, and expire September 28, 2031. The grant brought his reported option holdings to 75,000, including options previously issued to him.
Caring Brands, Inc. (CABR) director Christopher Melton received a grant of 50,000 stock options on September 28, 2026, under the company’s equity incentive plan. The options vested immediately, have an exercise price of $1.24 per share, and expire September 28, 2031. The reported total following the grant was 75,000 options, including options previously issued.
Caring Brands, Inc. director Christopher Matthew Galeta acquired 25,000 stock options on September 28, 2026, under the company’s equity incentive plan. The options vested immediately, have an exercise price of $1.24 per share, and expire September 28, 2031. The reported post-grant position was 50,000 options, including options previously issued to him. The Board approved the grant at the recommendation of the Compensation Committee.
Caring Brands, Inc. (CABR) reports that Chief Financial Officer Brian Meadows received a 25,000-option grant on September 28, 2026, covering 25,000 common shares at an exercise price of $1.24 per share. The Board of Directors approved the grant at the Compensation Committee’s recommendation under the company’s equity incentive plan. The options vested immediately and have an expiration date of September 28, 2031.
Caring Brands, Inc. (CABR) reports governance and executive changes along with an amendment to a consulting agreement. On September 18, 2026, the company entered into a First Amendment to its Consulting Services Agreement with Myall Luna Ventures Inc., under which Brian R. Meadows, through Myall Luna, will serve as Chief Financial Officer and perform duties customarily associated with that role for a public company.
Effective September 18, 2026, the monthly consulting fee payable to Myall Luna increased from $10,000 to $15,000, with all other payment terms unchanged. On September 16, 2026, Brian John ceased serving as Interim Chief Financial Officer, resigned as a director, and stepped down as Chairman of the Board, with his vested stock options remaining exercisable until their original expiration dates. The Board appointed Dr. Glynn Wilson as Chairman effective September 18, 2026, and confirmed Mr. Meadows, age 62, as full-time Chief Financial Officer and principal financial officer, after which he no longer qualifies as an independent director.
Caring Brands, Inc. (CABR) filed an initial ownership report for director Brian Meadows on Form 3. The filing lists him as a director and reports no transactions or derivative positions, and no holdings are shown in the non-derivative or derivative ownership tables in this report.
Caring Brands, Inc. (CABR) disclosed completion of a subsequent closing of its previously announced private placement of Series B Convertible Preferred Stock and warrants, adding $2,549,900 of gross proceeds on September 11, 2026. Together with the initial closing, the PIPE financing totals $7,149,900 of gross proceeds and an estimated $6,999,900 net cash increase after offering costs.
The preferred-stock PIPE and the reclassification of $3,852,686 of Series A preferred from mezzanine equity to permanent equity result in preliminary unaudited pro forma stockholders’ equity of $8,220,419 as of August 31, 2026, compared with Nasdaq’s $2,500,000 equity requirement. Nasdaq and its Hearings Panel must still determine whether equity compliance has been regained, and the company notes that further losses, dividends, or adjustments could reduce equity.